Cargando…
Cost-effective therapeutic hypothermia treatment device for hypoxic ischemic encephalopathy
Despite recent advances in neonatal care and monitoring, asphyxia globally accounts for 23% of the 4 million annual deaths of newborns, and leads to hypoxic-ischemic encephalopathy (HIE). Occurring in five of 1000 live-born infants globally and even more in developing countries, HIE is a serious pro...
Autores principales: | Kim, John J, Buchbinder, Nathan, Ammanuel, Simon, Kim, Robert, Moore, Erika, O’Donnell, Neil, Lee, Jennifer K, Kulikowicz, Ewa, Acharya, Soumyadipta, Allen, Robert H, Lee, Ryan W, Johnston, Michael V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540914/ https://www.ncbi.nlm.nih.gov/pubmed/23319871 http://dx.doi.org/10.2147/MDER.S39254 |
Ejemplares similares
-
Biomarkers in newborns with hypoxic-ischemic encephalopathy treated with therapeutic hypothermia
por: Michniewicz, Barbara, et al.
Publicado: (2020) -
Improving the Timeliness and Safety of Therapeutic Hypothermia for Hypoxic–Ischemic Encephalopathy
por: Smith, Hannah N., et al.
Publicado: (2020) -
Dexmedetomidine Pharmacokinetics in Neonates with Hypoxic-Ischemic Encephalopathy Receiving Hypothermia
por: McAdams, Ryan M., et al.
Publicado: (2020) -
Therapeutic Hypothermia for Neonatal Hypoxic–Ischemic Encephalopathy – Where to from Here?
por: Davidson, Joanne O., et al.
Publicado: (2015) -
Can we further optimize therapeutic hypothermia for hypoxic-ischemic encephalopathy?
por: Davies, Anthony, et al.
Publicado: (2019)